iridoids and Periodontal-Diseases

iridoids has been researched along with Periodontal-Diseases* in 2 studies

Trials

1 trial(s) available for iridoids and Periodontal-Diseases

ArticleYear
Preparation and evaluation of ketorolac tromethamine gel containing genipin for periodontal diseases.
    Archives of pharmacal research, 2007, Volume: 30, Issue:7

    Ketorolac tromethamine gel (KT gel) and ketorolac tromethamine gel containing genipin (KTG gel) were prepared and their therapeutic effects on periodontitis were evaluated. The skin permeation rate of ketorolac from the KT gel and KTG gel was 5.75+/-0.53 and 5.82 +/- 0.74 microg/cm2/ h, respectively. The skin permeation rate of genipin from the KTG gel was 10.13 +/- 1.47 microg/ cm2/h. The tensile strength of the KTG gel was larger than the KT gel. After 4 weeks, the periodontal pocket depth of the KTG gel group (3.22 +/- 0.20 mm) significantly decreased compared with the non-treated group (4.50 +/- 0.25 mm) and the KT group (3.84 +/- 00.26 mm). The KTG gel did not induce separation of the stratum corneum and subcutaneous tissue, and the collagen layers of the corium were closer, more fibrous, and showed longer connections than in the other groups. The KTG gel appears to be effective against gingivitis in the periodontal pocket through its increased anti-inflammatory activity and the crosslinking of genipin with the biological tissue.

    Topics: Adult; Animals; Chromatography, High Pressure Liquid; Double-Blind Method; Drug Combinations; Drug Compounding; Female; Gels; Humans; In Vitro Techniques; Iridoid Glycosides; Iridoids; Ketorolac Tromethamine; Male; Mice; Mice, Hairless; Middle Aged; Periodontal Diseases; Skin Absorption; Tensile Strength; Tissue Adhesives

2007

Other Studies

1 other study(ies) available for iridoids and Periodontal-Diseases

ArticleYear
Genipin inhibits IL-1β-induced CCL20 and IL-6 production from human periodontal ligament cells.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2014, Volume: 33, Issue:2

    Genipin, the aglycon of geniposide found in gardenia fruit has long been considered for treatment of various diseases in traditional oriental medicine. Genipin has been used as a blue colorant in food industry. Genipin has recently been reported to have some pharmacological functions, such as antimicrobial, antitumor, and anti-inflammatory effects. The aim of this study was to examine whether genipin could modify CCL20 and IL-6, which are related to bone resorption in periodontal disease, expression in human periodontal ligament cells (HPDLCs).. CCL20 and IL-6 productions from HPDLCs were determined by ELISA. Western blot analysis was used for the detection of signal transduction molecules expressions in HPDLCs.. Genipin prevented IL-1β-mediated CCL20 and IL-6 production in HPDLCs. Moreover, genipin could suppress nuclear factor kappa B (NF-κB) p65, extracellular signalregulated kinase (ERK) and MAPK/ERK kinase (MEK) phosphorylations in IL-1β-stimulated HPDLCs. NF-κB inhibitor and ERK inhibitor significantly inhibited IL-6 and CCL20 productions from IL-1β-stimulated HPDLCs.. These data provide a novel mechanism through which genipin could be used to provide direct benefits in periodontal disease to inhibit IL-6 and CCL20 productions in periodontal lesions.

    Topics: Cells, Cultured; Chemokine CCL20; Cholagogues and Choleretics; Humans; Interleukin-1beta; Interleukin-6; Iridoids; Periodontal Diseases; Periodontal Ligament

2014